IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 217 filers reported holding IMMUNOGEN INC in Q2 2021. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $102,947 | -3.7% | 25,482 | +13.7% | 0.01% | -14.3% |
| Q4 2022 | $106,877 | -17.8% | 22,406 | -1.7% | 0.01% | -22.2% |
| Q3 2022 | $130,000 | +32.7% | 22,794 | +10.1% | 0.01% | +28.6% |
| Q2 2022 | $98,000 | +34.2% | 20,695 | -0.8% | 0.01% | +16.7% |
| Q1 2022 | $73,000 | -41.1% | 20,856 | -6.9% | 0.01% | -33.3% |
| Q4 2021 | $124,000 | -27.9% | 22,394 | -26.4% | 0.01% | -25.0% |
| Q3 2021 | $172,000 | -50.0% | 30,417 | -50.8% | 0.01% | -7.7% |
| Q2 2021 | $344,000 | +72.9% | 61,874 | +152.8% | 0.01% | -18.8% |
| Q1 2021 | $199,000 | – | 24,477 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |